Chemoinformaics analysis of CHRYSOPHANOL-1-BETA-GENTIOBIOSIDE
| Molecular Weight | 578.523 | nRot | 6 |
| Heavy Atom Molecular Weight | 548.283 | nRig | 30 |
| Exact Molecular Weight | 578.164 | nRing | 5 |
| Solubility: LogS | -2.145 | nHRing | 2 |
| Solubility: LogP | -0.496 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
| nHA | 14 | APOL | 76.3218 |
| nHD | 8 | BPOL | 38.7762 |
| QED | 0.151 |
| Synth | 4.584 |
| Natural Product Likeliness | 1.617 |
| NR-PPAR-gamma | 0.882 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.183 |
| Pgp-sub | 0.972 |
| HIA | 0.987 |
| CACO-2 | -6.213 |
| MDCK | 0.0000536 |
| BBB | 0.303 |
| PPB | 0.704584 |
| VDSS | 0.632 |
| FU | 0.170535 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.106 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.138 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.037 |
| CL | 1.386 |
| T12 | 0.192 |
| hERG | 0.017 |
| Ames | 0.779 |
| ROA | 0.031 |
| SkinSen | 0.024 |
| Carcinogencity | 0.744 |
| EI | 0.016 |
| Respiratory | 0.007 |
| NR-Aromatase | 0.706 |
| Antiviral | Yes |
| Prediction | 0.859019 |